Divi's Laboratories Ltd DIVISLAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹11,565.50
- Day Range
- ₹11,190.00–11,800.50
- 52-Week Range
- ₹5,647.50–11,824.00
- Bid/Ask
- ₹11,350.00 / ₹11,367.00
- Shares Outstanding
- 265.47M
- Market Cap
- ₹3.02T
- Volume/Avg
- 2M / 592,836
Key Statistics
- Price/Earnings (Normalized)
- 86.54
- Price/Sales
- 24.74
- Dividend Yield (Trailing)
- 0.26%
- Dividend Yield (Forward)
- 0.26%
- Dividend Payment Schedule
- Aug
- Total Yield
- 0.26%
Company Profile
Divi's Laboratories Ltd is engaged in the manufacture of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical Ingredients, with predominance in exports. Through its custom synthesis business, the Company supports innovator pharma companies for patented products from gram-scale requirements for clinical trials to launch and late-life cycle management, in addition to generics. It operates in a single operating segment, Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceutical Ingredients. The Company derives maximum revenue from Europe.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 9,634
- Website
- https://www.divislabs.com
Valuation
Metric | DIVISLAB |
|---|---|
Price/Earnings (Normalized) | 86.54 |
Price/Book Value | 16.77 |
Price/Sales | 24.74 |
Price/Cash Flow | 81.53 |
Price/Earnings
DIVISLAB
Financial Strength
Metric | DIVISLAB |
|---|---|
Quick Ratio | 2.12 |
Current Ratio | 4.60 |
Interest Coverage | 143.84 |
Quick Ratio
DIVISLAB
Profitability
Metric | DIVISLAB |
|---|---|
Return on Assets (Normalized) | 16.93% |
Return on Equity (Normalized) | 20.30% |
Return on Invested Capital (Normalized) | 20.40% |
Return on Assets
DIVISLAB
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|?pBNj<>T | LOCK|jM<% | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|bGBdJ<h | LOCK|@>b!K | $50B | |||
| Haleon PLC ADR HLN | LOCK|M>>@&& | LOCK|S%J | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|CdsGM$k | LOCK|jm | $34B | |||
| Viatris Inc VTRS | LOCK|RxW<q$ | LOCK|^h | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|%Z | LOCK|@X | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|B&W#Nk | LOCK|sSt | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|Hl^lTC | LOCK|N%G | $4B | |||
| Perrigo Co PLC PRGO | LOCK|FRVNkG | LOCK|hf | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|VqCLn!L | LOCK|vkbr | $2B |
United States